RITUXAN HYCELA® (rituximab/hyaluronidase human) is indicated for the treatment of adult patients with:
Limitations of Use
BOXED WARNINGS: SEVERE MUCOCUTANEOUS REACTIONS, HEPATITIS B VIRUS REACTIVATION and PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Severe Mucocutaneous Reactions
Hepatitis B Virus Reactivation
Progressive Multifocal Leukoencephalopathy (PML)
Hypersensitivity and Other Administration Reactions
Local Cutaneous Reactions
Tumor Lysis Syndrome (TLS)
Cardiovascular Adverse Reactions
Bowel Obstruction and Perforation
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
The BrandX™ Co-pay Card Program may help lower the out-of-pocket costs for your patients.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.